Skip Navigation

Program Title: Managed Access Program MAP to provide access to CTL019, for acute lymphoblastic leukemia ALL or large B-cell lymphoma patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release

Brief Summary

Type:
Other

Study Type:
Other

Phase:
N/A

ClinicalTrials.gov Identifier:
NCT03601442

Study #:
STUDY00144517

Start Date:
Feb 13, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03601442

View Complete Trial Details & Eligibility at ClinicalTrials.gov